Responses
Immunotherapy biomarkers
Original research
Pretreatment metastatic growth rate determines clinical outcome of advanced melanoma patients treated with anti-PD-1 antibodies: a multicenter cohort study
Compose a Response to This Article
Other responses
No responses have been published for this article.